LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.71 | 27.76 | 325 | 2877 | 0.1129 | 0.4440 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.41 | 27.76 | 4 | 3105 | 0.0013 | -0.2477 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.41 | 27.76 | 546 | 3105 | 0.1758 | 0.5492 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.41 | 27.76 | 1 | 3105 | 0.0003 | -0.3864 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.41 | 27.76 | 171 | 3105 | 0.0551 | 0.3062 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.11 | 27.76 | 6 | 3331 | 0.0018 | -0.1989 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.11 | 27.76 | 576 | 3331 | 0.1729 | 0.5512 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.11 | 27.76 | 1 | 3331 | 0.0003 | -0.3820 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.11 | 27.76 | 88 | 3331 | 0.0264 | 0.1818 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.81 | 27.76 | 10 | 3596 | 0.0028 | -0.1354 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.81 | 27.76 | 520 | 3596 | 0.1446 | 0.5183 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.81 | 27.76 | 1 | 3596 | 0.0003 | -0.3773 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 42.81 | 27.76 | 18 | 3596 | 0.0050 | -0.0599 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.52 | 27.76 | 9 | 3884 | 0.0023 | -0.1462 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.52 | 27.76 | 576 | 3884 | 0.1483 | 0.5302 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.52 | 27.76 | 1 | 3884 | 0.0003 | -0.3726 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 44.52 | 27.76 | 8 | 3884 | 0.0021 | -0.1601 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.22 | 27.76 | 14 | 4125 | 0.0034 | -0.0905 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.22 | 27.76 | 576 | 4125 | 0.1396 | 0.5224 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.22 | 27.76 | 1 | 4125 | 0.0002 | -0.3691 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 46.22 | 27.76 | 2 | 4125 | 0.0005 | -0.3055 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.93 | 27.76 | 6 | 4421 | 0.0014 | -0.1889 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.93 | 27.76 | 555 | 4421 | 0.1255 | 0.5060 | MN20160318_Q01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.93 | 27.76 | 1 | 4421 | 0.0002 | -0.3651 | MN20160318_Q01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.93 | 27.76 | 1 | 4421 | 0.0002 | -0.3651 | MN20160318_Q01 | L09 |